Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

Benzer Materyaller

• Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
  Yazar:: Patick, A K, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.
  Yazar:: Deminie, C A, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
  Yazar:: Bechtold, C M, ve diğerleri
  Baskı/Yayın Bilgisi: (1995)
• Potentiation of the stavudine anti-human immunodeficiency virus activity by 5-fluorouracil.
  Yazar:: Gong, Y F, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
  Yazar:: Gong, Yi-Fei, ve diğerleri
  Baskı/Yayın Bilgisi: (2000)